Search results
Results from the WOW.Com Content Network
Alteplase, sold under the brand name Activase among others, is a biosynthetic form of human tissue-type plasminogen activator (t-PA). It is a thrombolytic medication used to treat acute ischemic stroke, acute ST-elevation myocardial infarction (a type of heart attack), pulmonary embolism associated with low blood pressure, and blocked central venous catheter. [5]
There is consensus amongst stroke specialists that tPA is the standard of care for eligible stroke patients, and benefits outweigh the risks. There is significant debate mainly in the emergency medicine community regarding recombinant tPA's effectiveness in ischemic stroke.
Alteplase is a recombinant tissue plasminogen activator which enhances the conversion of plasminogen into plasmin to aid in the degradation of blood clots. [31] Effectiveness depends highly on swift administration of the medication, notably, the treatment should be administered within 3 to 4.5 hours of onset of the ischaemic stroke for the most ...
Stroke is a medical condition in which poor blood flow to a part of the brain causes cell death. [5] There are two main types of stroke: ischemic, due to lack of blood flow, and hemorrhagic, due to bleeding. [5]
Cerebral infarction, also known as an ischemic stroke, is the pathologic process that results in an area of necrotic tissue in the brain (cerebral infarct). [1] In mid to high income countries, a stroke is the main reason for disability among people and the 2nd cause of death. [2]
Tenecteplase is a 527 amino acid glycoprotein developed by introducing the following modifications to the complementary DNA for natural human tPA: a substitution of threonine 103 with asparagine, and a substitution of asparagine 117 with glutamine, both within the kringle 1 domain, and a tetra-alanine substitution at amino acids 296–299 in ...
These results and the first mentioning of the term ischemic penumbra were published in 1977 in Stroke (1), and further substantiated by an editorial in 1981 (2). The first decade of research focused on physiologic profile of the penumbra tissue after stroke , mapping the cerebral blood flow, and quantifying oxygen and glucose consumption to ...
The National Institutes of Health Stroke Scale, or NIH Stroke Scale (NIHSS), is a tool used by healthcare providers to objectively quantify the impairment caused by a stroke and aid planning post-acute care disposition, though was intended to assess differences in interventions in clinical trials. The NIHSS was designed for the National ...